EGFR and non-small cell lung carcinoma: Several ORF screens performed on EGFR mutant NSCLC lines have discovered novel mutations as well as previously characterized oncogenes that can help cells escape EGFR dependency through reactivation of the MAPK and PI3K/AKT pathway.